L. Masques, Il est a appliqué après le shampooing sur des cheveux essorés. Laisser-le agir 5 à 20 minutes puis rincer abondamment. Le faire 1 à 2 fois/ semaine au début puis 1 fois tous les quinze jours en entretien, Ils ont généralement les mêmes noms que les shampooings

L. Huiles, A appliquer sur les cheveux secs et laisser poser 10 à 30 minutes. Rincer puis procéder au shampooing, à réaliser 1 fois/ semaine

A. Melissopoulos and C. Levacher, Les annexes cutanées. Dans : La peau : structure et physiologie, édition Lavoisier, pp.57-99, 1998.

P. Bouhanna, Les alopécies de la clinique aux traitements. France : édition med'com, 2004.

P. Bouhanna, Soigner et préserver ses cheveux. France : Edition Alpen, 2006.

R. Aziza and M. Padioleau, Bien dans ses cheveux, toutes les solutions pour traiter la chute des cheveux. France : Mimi editions, 2000.

M. Estrade, Conseil en cosmétologie. 2 ème éd. France : Groupe liaisons SA, 2006.100-Bobin MF

M. Martini, Introduction à la dermopharmacie et à la cosmétique. 3 ème édition

M. Martini and M. Seiller, Actifs et additifs en cosmétologie. 3 ème éd. France : Tec & Doc, 2006.

M. Martini and . Esthétique-cosmétique, Tome 2 : cosmétologie. 2 ème édition

B. Bernard and . M. La-vie-révélée-du-follicule-de-cheveu-humain, La vie r??v??l??e du follicule de cheveu humain, m??decine/sciences, vol.22, issue.2, pp.138-143, 2006.
DOI : 10.1051/medsci/2006222138

URL : http://www.erudit.org/revue/ms/2006/v22/n2/012381ar.pdf

. Méd and . Chir, Dermatologie. 98-020-A-10, p.6

J. Rees, Genetics of Hair and Skin Color, Annual Review of Genetics, vol.37, issue.1, pp.67-90, 2003.
DOI : 10.1146/annurev.genet.37.110801.143233

M. Chavéron and S. Lachgar, Croissance pilaire : VEGF et fibroblastes de la papille folliculaire, Ann dermatol venereol, issue.2, pp.9-11, 1998.

R. Hoffmann, Interaction hormonale et croissance du cheveu, Ann Dermatol Veneorol, vol.129, pp.787-792, 2002.

L. Goldberg and Y. Lenzy, Nutrition and hair, Clinics in Dermatology, vol.28, issue.4, pp.412-418, 2010.
DOI : 10.1016/j.clindermatol.2010.03.038

L. Misery, S. Touboul, C. Vincot, S. Dutray, G. Rollard-jacob et al., Stress et dermatite s??borrh??ique, Annales de Dermatologie et de V??n??r??ologie, vol.134, issue.11, pp.833-837, 2007.
DOI : 10.1016/S0151-9638(07)92826-4

P. Reygane and . Alopécies, Encycl Méd Chir, AKOS, pp.2-065, 2002.

A. Tosti, C. Misciali, B. Piraccini, A. Peluso, and F. Bardazzi, Drug-Induced Hair Loss and Hair Growth, Drug Safety, vol.10, issue.4, p.310, 1994.
DOI : 10.2165/00002018-199410040-00005

P. Reygane, Pourquoi le follicule pileux est-il si sensible aux agents toxiques et iatrog??nes ?, Annales de Dermatologie et de V??n??r??ologie, vol.134, issue.4, pp.353-359, 2007.
DOI : 10.1016/S0151-9638(07)92818-5

O. Dereure, D. Bessis, J. Guilhou, and B. Guillot, Effets cutan??s ind??sirables des chimioth??rapies antitumorales et des cytokines, EMC - Dermatologie, vol.1, issue.1, pp.98-712, 2002.
DOI : 10.1016/S0246-0319(02)00095-X

B. Sassolas and C. Garcia, Colchicine en dermatologie. Encycl Méd Chir, Dermatologie, pp.98-912, 2003.
DOI : 10.1016/s0246-0319(03)29247-5

J. Berth-jones and P. Hutchinson, Novel cycle changes in scalp hair are caused by etretinate therapy, British Journal of Dermatology, vol.9, issue.3, pp.367-375, 1995.
DOI : 10.1001/archderm.129.3.356

J. Berth-jones, D. Shuttleworth, and P. Hutchinson, A study of etretinate alopecia, British Journal of Dermatology, vol.83, issue.6, pp.751-755, 1990.
DOI : 10.1111/j.1365-2133.1990.tb06262.x

R. Yassa, Hair loss during lithium therapy, Am J Psychiatry Jul, vol.143, issue.7, p.943, 1986.

I. Elalamy, Héparines: structure, proprieties pharmacologiques et activités. Encycl Méd Chir, Hématologie, pp.13-022, 2010.
DOI : 10.1016/s1155-1984(10)39844-x

K. Schulpis, G. Karikas, and J. Tjamouranis, Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy, Epilepsia, vol.60, issue.suppl 5, pp.1359-62, 2001.
DOI : 10.1046/j.1528-1157.2001.47000.x

M. Arslan, S. Vurucu, and N. Balamtekin, The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid, Brain and Development, vol.31, issue.6, pp.405-415, 2009.
DOI : 10.1016/j.braindev.2008.07.008

. Selenium, zinc, and copper changes with valproic acid: Possible relation to drug side effects, Neurology, vol.34, pp.1393-1395, 1984.

E. Ginarte, E. Losada, A. Prieto, V. Lorenzo-zuniga, and J. Toribio, Generalized hair loss induced by indinavir plus ritonavir therapy, AIDS, vol.16, issue.12, pp.1695-1696, 2002.
DOI : 10.1097/00002030-200208160-00021

J. Sass, B. Jakob-sölder, A. Heitger, G. Tzimas, and M. Sarcletti, Paronychia with Pyogenic Granuloma in a Child Treated with Indinavir: The Retinoid-Mediated Side Effect Theory Revisited, Dermatology, vol.200, issue.1, pp.40-42, 2002.
DOI : 10.1159/000018313

E. Toma, D. Devost, C. Lan, N. Bhat, and P. , HIV-protease inhibitors alter retinoic acid synthesis, AIDS, vol.15, issue.15, pp.1979-1984, 2001.
DOI : 10.1097/00002030-200110190-00010

C. Martin, E. Southwick, and H. Maibach, Propranolol induced alopecia, American Heart Journal, vol.86, issue.2, pp.236-237, 1973.
DOI : 10.1016/0002-8703(73)90250-0

A. Bhattacharya, D. Roy, S. Hazarika, S. Das, K. Nath et al., Alopecia areata associated with haloperidol decanoate long-acting injection, Australian & New Zealand Journal of Psychiatry, vol.32, issue.1, p.69, 2012.
DOI : 10.1177/0004867411431776

E. Peters, M. Maurer, V. Botchkarev, D. Gordon, and R. Paus, Hair growth-modulation by adrenergic drugs, Experimental Dermatology, vol.84, issue.4, pp.274-281, 1999.
DOI : 10.1111/j.1600-0625.1999.tb00382.x

J. Kantor, L. Kessler, D. Brooks, and G. Cotsarelis, Decreased Serum Ferritin is Associated With Alopecia in Women, Journal of Investigative Dermatology, vol.121, issue.5, pp.985-988, 2003.
DOI : 10.1046/j.1523-1747.2003.12540.x

D. Rushton, Nutritional factors and hair loss, Clinical and Experimental Dermatology, vol.127, issue.1, pp.396-404, 2002.
DOI : 10.1046/j.0412-5463.2001.00110.x

M. Sawaya and V. Price, Different Levels of 5??-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia, Journal of Investigative Dermatology, vol.109, issue.3, pp.226-300, 1997.
DOI : 10.1111/1523-1747.ep12335779

F. Blanc, Encycl Méd Chir, Dermatologie, pp.98-810, 1999.

M. Martini and . Tensioactifs, Encycl Méd Chir, Cosmétologie et dermatologie esthétique, pp.50-120, 2006.

C. Bouillon, Shampoings et soins embellisseurs Encycl Méd Chir, Cosmétologie et dermatologie esthétique, pp.50-190, 2000.
DOI : 10.1016/s1283-0143(06)75079-8

B. Arechabala and C. Coiffard, Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release, Journal of Applied Toxicology, vol.107, issue.3, pp.163-165, 1999.
DOI : 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H

O. Bayrou and C. Jouanique, Effets indésirables des soins capillaires. Encycl Méd Chir, Cosmétologie et dermatologie esthétique, pp.50-190, 2001.
DOI : 10.1016/s1283-0143(06)75081-6

J. Fowler, Allergy to cocamide DEA, Am J Contact Dermatol, vol.9, pp.40-41, 1998.

M. Martini and . Les, Encycl Méd Chir, Cosmétologie et dermatologie esthétique, pp.50-120, 2006.

M. Ghannoum, M. Thomson, W. Bowman, and S. Khalil, Mode of action of the antimicrobial compound 5-Bromo-5-nitro-1,3-dioxane (Bronidox), Folia Microbiologica, vol.36, issue.1, pp.19-31, 1986.
DOI : 10.1007/BF02928676

T. Nguyen, C. B. Guo, W. Martinac, and B. , The effects of parabens on the mechanosensitive channels of E.Coli, Eur Biophys J, vol.34, pp.385-95, 2005.

S. Cooper and S. Shaw, Allergic contact dermatitis from parabens in a tar shampoo, Contact Dermatitis, vol.39, issue.3, p.140, 1998.
DOI : 10.1111/j.1600-0536.1995.tb00476.x

P. Darbre, Environmental oestrogens, cosmetics and breast cancer, Best Practice & Research Clinical Endocrinology & Metabolism, vol.20, issue.1, pp.121-143, 2006.
DOI : 10.1016/j.beem.2005.09.007

R. Elder, Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben, J Am Coll Res, vol.3, pp.147-209, 1984.

V. Scott, E. Yu, and R. , Control of keratinization with a-hydroxy acids and related compounds. Topical treatment of ichthyotic disorders, Arch Dermatol, vol.110, pp.586-590, 1974.

C. Pierard-franchimont, G. Pierard, V. Vroome, G. Lin, and Y. Appa, Comparative Anti-Dandruff Efficacy between a Tar and a Non-Tar Shampoo, Dermatology, vol.200, issue.2, pp.181-184, 2000.
DOI : 10.1159/000018362

D. Shuttleworth, R. Squire, G. Boorman, and K. Goode, Comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) or ketoconazole (2%; Nizoral??) for the control of dandruff/seborrhoeic dermatitis, Journal of Dermatological Treatment, vol.102, issue.4, pp.157-162, 1998.
DOI : 10.3109/09546639809160547

B. Matard and P. Reygagne, Soins antipelliculaires. Encycl Méd Chrir, Cosmétologie et dermatologie esthétique, pp.50-190, 2001.
DOI : 10.1016/s1283-0143(06)75082-8

M. Loden and C. Wessman, The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo, International Journal of Cosmetic Science, vol.37, issue.4, pp.285-289, 2000.
DOI : 10.1046/j.1467-2494.2000.00024.x

P. Reygagne and . Cheveu, Cheveu, vieillissement et environnement : aspects cliniques ??pid??miologiques, Annales de Dermatologie et de V??n??r??ologie, vol.136, pp.22-24, 2009.
DOI : 10.1016/S0151-9638(09)72393-2

A. Shemesh and W. Mayo, Australian tea tree oil: a natural antiseptic and fungicidal agent, Aust J Pharm, vol.72, pp.802-803

B. Matard and P. Reygagne, Traitements antichutes. Encycl Méd Chir, Cosmétologie et dermatologie esthétique, pp.50-190, 2002.
DOI : 10.1016/s1283-0143(06)75083-x

H. Yanagisaxa, Zinc deficiency and clinical practice-validity of zinc preparation

A. Messenger and J. Rundergren, Minoxidil: mechanisms of action on hair growth, British Journal of Dermatology, vol.41, issue.2
DOI : 10.1067/mjd.2002.124088

H. Baden and J. Kubilus, Effect of Minoxidil on Cultured Keratinocytes, Journal of Investigative Dermatology, vol.81, issue.6, pp.558-560, 1983.
DOI : 10.1111/1523-1747.ep12523220

. Ne-rgers, Medical treatments for male and female pattern hair loss, Journal of the American Academy of Dermatology, vol.59, issue.4, pp.547-566, 2008.
DOI : 10.1016/j.jaad.2008.07.001

V. Price, Treatment of hair loss, N Engl J Med, vol.23, pp.964-973, 1999.

P. Assouli and C. , Etude comparative d'un nouveau traitement dans l'alopécie androgénique masculine. Essai randomisé versus minoxidil à 2p. 100, Nouv Dermatol, 1997.

D. Villez, R. Jacobs, J. Szpunar, C. Warner, and M. , Androgenetic alopecia in the female treatment with 2% topical minoxidil solution, Arch Dermatol, vol.130, pp.303-307, 1994.

A. Lucky, D. Picquadio, C. Ditre, F. Dunlap, I. Kantor et al., A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss, Journal of the American Academy of Dermatology, vol.50, issue.4, pp.541-53, 2004.
DOI : 10.1016/j.jaad.2003.06.014

E. Olsen, Female pattern hair loss, J Am Acad Dermatol, vol.18, pp.1073-1077, 1988.
DOI : 10.1067/mjd.2002.124068

K. Kaufman, Finasteride in the treatment of men with androgenetic alopecia, Journal of the American Academy of Dermatology, vol.39, issue.4, pp.578-589, 1998.
DOI : 10.1016/S0190-9622(98)70007-6

M. Lorizzo, C. Vincenzi, S. Voudouris, B. Piraccini, and A. Tosti, Finasteride treatment of female pattern hair loss, Arch Dermatol, vol.142, issue.3, pp.298-302, 2006.

P. Vexiau, C. Chaspoux, P. Boudou, J. Fiet, C. Jouanique et al., Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial, British Journal of Dermatology, vol.16, issue.6, pp.992-999, 2002.
DOI : 10.1016/0022-4731(75)90311-8

I. Ramsay and D. Rushton, Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia, Clinical and Experimental Dermatology, vol.97, issue.4, pp.277-281, 1990.
DOI : 10.1007/BF01347138

D. Rushton and I. Ramsay, The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women, Clinical Endocrinology, vol.53, issue.4, pp.421-427, 1992.
DOI : 10.1111/j.1365-2230.1989.tb00881.x

L. Cusan, A. Dupont, A. Belanger, R. Tremblay, G. Manhez et al., Treatment of hirsutism with the pure antiandrogen flutamide, Journal of the American Academy of Dermatology, vol.23, issue.3, pp.462-469, 1990.
DOI : 10.1016/0190-9622(90)70241-9

R. Sinclair, M. Wewerinke, and D. Jolley, Treatment of female pattern hair loss with oral antiandrogens, British Journal of Dermatology, vol.44, issue.3, pp.466-473, 2005.
DOI : 10.1046/j.1523-1747.2001.01261.x

R. T. Raudrant, Progestogens with Antiandrogenic Properties, Drugs, vol.54, issue.5, pp.463-492, 2003.
DOI : 10.2165/00003495-200363050-00003